Mitsubishi Tanabe Pharma Corp.

Company NameMitsubishi Tanabe Pharma Corp.
PI Number19
Revenue (Millions)$5,292
Total Equity (Millions)$9,074
Net Income (Millions)$488
Revenue Growth1.18%
Profit Margin 19.22%
Earnings per ShareN/A
Debt to Equity RatioN/A
Return on Equity5.55%
Cost of Goods Sold (Millions)$1,997
Earnings per Share GrowthN/A
Total Assets (Millions)$10,579
Current Liabilities (Millions)$1,586
Long Term Debt (Millions)N/A